Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year: K roll-Desrosiers et al.
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Due to its potent effects on social behavior, including maternal behavior, oxytocin has been identified as a potential mediator of postpartum depression and anxiety. The objective of this study was to examine the relationship between peripartum synthetic oxytocin administration and the development of depressive and anxiety disorders within the first year postpartum. We hypothesized that women exposed to peripartum synthetic oxytocin would have a reduced risk of postpartum depressive and anxiety disorders compared with those without any exposure. METHODS: Population-based data available through the Massachusetts Integrated Clinical Academic Research Database (MiCARD) were used to retrospectively (2005-2014) examine this relationship and calculate the relative risk of peripartum synthetic oxytocin for the development of postpartum depressive and anxiety disorders in exposed (n = 9,684) compared to unexposed (n = 37,048) deliveries. RESULTS: Among deliveries to women with a history of prepregnancy depressive or anxiety disorder, exposure to peripartum oxytocin increased the risk of postpartum depressive or anxiety disorder by 36% (relative risk (RR): 1.36; 95% confidence interval (95% CI): 1.20-1.55). In deliveries to women with no history of prepregnancy depressive or anxiety disorder, exposure to peripartum oxytocin increased the risk of postpartum depressive or anxiety disorder by 32% compared to those not exposed (RR: 1.32; 95% CI: 1.23-1.42). CONCLUSIONS: Contrary to our hypothesis, results indicate that women with peripartum exposure to synthetic oxytocin had a higher relative risk of receiving a documented depressive or anxiety disorder diagnosis or antidepressant/anxiolytic prescription within the first year postpartum than women without synthetic oxytocin exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091379 · Cited by 7,067 · cited 1×
“Inclusion of both diagnostic and medication prescription codes acknowledges the importance of assessing both diagnoses and symptoms, in line with Research Domain Criteria (RDoC) initiative (Insel et al., 2010).”
Gaynes, B. N., Gavin, N., Meltzer-Brody, S., Lohr, K. N., Swinson, T., Gartlehner, G., Brody, S., & Miller, W. C. (2005) · PsycEXTRA Dataset · doi:10.1037/e439372005-001 · Cited by 1,211
Psychiatric Disorders in Pregnant and Postpartum Women in the United States
Vesga-López, O., Blanco, C., Keyes, K., Olfson, M., Grant, B. F., & Hasin, D. S. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.7.805 · Cited by 1,065 · cited 2×
“Postpartum depressive and anxiety disorders are diagnosed in up to 12.9 and 20.4% of women, respectively (Austin et al., 2010; Gaynes et al., 2005; Reck et al., 2008; Vesga-Lopez et al., 2008), and adversely affectmothers and their offspring (Earls, 2010; Goodman, 2007).”
BackgroundInfluentialPrevalence of suicidality during pregnancy and the postpartum
Lindahl, V., Pearson, J. L., & Colpe, L. (2005) · Archives of Women’s Mental Health · doi:10.1007/s00737-005-0080-1 · Cited by 795
Feldman, R., Weller, A., Zagoory-Sharon, O., & Levine, A. (2007) · Psychological Science · doi:10.1111/j.1467-9280.2007.02010.x · Cited by 787
Cross-cultural and social diversity of prevalence of postpartum depression and depressive symptoms
Halbreich, U., & Karkun, S. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.12.051 · Cited by 776
Feldman, R., Granat, A., Pariente, C., Kanety, H., Kuint, J., & Gilboa-Schechtman, E. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181b21651 · Cited by 747 · cited 1×
“For offspring, maternal postpartum depression is associated with difficult infant and childhood temperament (Britton, 2011; Feldman et al., 2009), attachment insecurity (Forman et al.”
BackgroundGoodman, S. H. (2007) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.3.022806.091401 · Cited by 609
FORMAN, D. R., O'HARA, M. W., STUART, S., GORMAN, L. L., LARSEN, K. E., & COY, K. C. (2007) · Development and Psychopathology · doi:10.1017/s0954579407070289 · Cited by 485 · cited 1×
“…postpartum depression is associated with difficult infant and childhood temperament (Britton, 2011; Feldman et al., 2009), attachment insecurity (Forman et al., 2007), developmental delays (Deave, Heron, Evans, & Emond, 2008), changes in cognitive development (Azak, 2012; Murray & Cooper, 1997;…”
BackgroundThe impact of maternal depression in pregnancy on early child development
Deave, T., Heron, J., Evans, J., & Emond, A. (2008) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01752.x · Cited by 479
Cited by
The oxytocin receptor: from intracellular signaling to behavior
Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999
Pathophysiological mechanisms implicated in postpartum depression
Payne, J. L., & Maguire, J. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.12.001 · Cited by 459
Is oxytocin “nature’s medicine”
Carter, C. S., Kenkel, W. M., MacLean, E. L., Wilson, S. R., Perkeybile, A. M., Yee, J. R., Ferris, C. F., Nazarloo, H. P., Porges, S. W., Davis, J. M., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019398 · Cited by 394
Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development
Frieder, A., Fersh, M., Hainline, R., & Deligiannidis, K. M. (2019) · CNS Drugs · doi:10.1007/s40263-019-00605-7 · Cited by 156
Self-citationOxytocin during breastfeeding and maternal mood symptoms
Whitley, J., Wouk, K., Bauer, A. E., Grewen, K., Gottfredson, N. C., Meltzer-Brody, S., Propper, C., Mills-Koonce, R., Pearson, B., & Stuebe, A. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104581 · Cited by 61
Furtado, M., Van Lieshout, R. J., Van Ameringen, M., Green, S. M., & Frey, B. N. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.064 · Cited by 50
Metadata
- Authors
- Kroll-Desrosiers, A. R., Nephew, B. C., Babb, J. A., Guilarte-Walker, Y., Moore Simas, T. A., & Deligiannidis, K. M.
- Venue
- Depression and Anxiety
- Publisher
- Wiley
- Published
- 2017-01-30
- Volume
- 34
- Issue
- 2
- Pages
- 137-146
- ISSN
- 1091-4269 (ISSN-L)
- OpenAlex
- W2582562037
- Cited by
- 98
- References
- 25
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.